---
title: "Telehealth Use Among US Adults Fell After the COVID-19 PHE: 2022–2024 HINTS Analysis"
id: "medrxiv-3-the-evolving-role-of-telehealth-in-routine-health-care-delivery-among-us-adults"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-the-evolving-role-of-telehealth-in-routine-health-care-delivery-among-us-adults"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1?rss=1"
published_at: "2026-11-10T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Telehealth Use Among US Adults Fell After the COVID-19 PHE: 2022–2024 HINTS Analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-the-evolving-role-of-telehealth-in-routine-health-care-delivery-among-us-adults
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1?rss=1)
- **Published At:** 2026-11-10T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors analyzed nationally representative survey data from the Health Information National Trends Survey (**HINTS**) collected in 2022 and 2024 to measure changes in **telehealth** use among US adults. - The serial cross-sectional dataset included a total sample of 13,141 respondents across the two cycles; survey-weighted estimates were used to project population-level prevalence. - Reported prevalence of any **telehealth** use decreased from 39.3% in 2022 to 34.5% in 2024; adjusted analyses produced an aOR of 0.81 (95% CI, 0.69–0.95) for 2024 versus 2022. - Higher adjusted odds of **telehealth** use were observed in adults aged 35–49 years, adults with a college degree or higher, insured adults, those with a history of cancer, and those with diagnosed depression or anxiety. - All surveyed self-reported motivations for **telehealth** use declined between cycles. The proportion citing infection avoidance fell markedly (50.2% to 19.1%), and provider recommendation/requirement also declined (72.8% to 47.2%). - **Convenience** declined less steeply (65.6% to 56.2%) and emerged as the most commonly reported reason for telehealth use in 2024. - The study team used survey-weighted multivariable logistic regression and multiple imputation for missing data; the preprint notes the research has not been peer reviewed and that data are publicly available via HINTS. - The findings suggest a shift from pandemic-driven demand toward selective integration of **telehealth** into routine care, with persistent inequalities in access and use across population groups.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ZCwtzlzSZt3XftH0uRXq2.MM1l2CCcU9u_dHbv.wNd0-1794369054.2159793-1.2.1.1-fiBsF26dLeCB_.1fDcbkg4Eia37rIRRNIIe.GYAR3ntj8_VcJMdZ3eQxBBEBogBN) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # The Evolving Role of Telehealth in Routine Health Care Delivery Among US Adults, 2022-2024 Shengyang Wang, Wenxue Lin, [ View ORCID Profile](http://orcid.org/0000-0002-8180-9615)Lin Ge doi: https://doi.org/10.64898/2026.11.09.26367679 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Shengyang Wang Indiana University Bloomington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shengyang%2BWang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wang%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AShengyang%2BWang%2B) Wenxue Lin Indiana University Bloomington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Wenxue%2BLin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lin%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWenxue%2BLin%2B) Lin Ge Indiana University Bloomington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lin%2BGe%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ge%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALin%2BGe%2B) * [ORCID record for Lin Ge](http://orcid.org/0000-0002-8180-9615 "Open in new tab") * For correspondence: lge_biostat@outlook.com * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1341709/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1341709/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1341709/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1341709/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1341709/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Telehealth use expanded rapidly during the COVID-19 pandemic, but its role following the end of the public health emergency (PHE) remains incompletely understood. This study examined changes in telehealth utilization among US adults between 2022 and 2024, characteristics associated with use, and changes in self-reported reasons for using telehealth to understand its evolving role. Methods: This serial cross-sectional study analyzed nationally representative data from 13 141 US adults participating in the Health Information National Trends Survey (HINTS) in 2022, during the COVID-19 PHE, and 2024, after the PHE ended. Survey-weighted analyses were used to estimate telehealth utilization and self-reported reasons for use. Survey-weighted multivariable logistic regression was used to examine changes between survey cycles and sociodemographic and health-related characteristics associated with telehealth utilization. Multiple imputation was used to address missing data. Results: Telehealth utilization declined from 39.3% in 2022 to 34.5% in 2024; after adjustment for sociodemographic and health-related characteristics, the odds of telehealth use were significantly lower in 2024 than in 2022 (adjusted odds ratio [aOR], 0.81; 95% CI, 0.69-0.95). Telehealth utilization differed across population groups. Higher odds of use were observed among adults aged 35 to 49 years (aOR, 1.47; 95% CI, 1.19-1.82), those with a college degree or higher (aOR, 1.93; 95% CI, 1.31-2.86), those with diagnosed depression or anxiety (aOR, 2.86; 95% CI, 2.46-3.33), those with a history of cancer (aOR, 1.40; 95% CI, 1.15-1.69), and insured adults (aOR, 1.52; 95% CI, 1.13-2.04). All self-reported reasons for telehealth use declined between 2022 and 2024. Infection avoidance decreased from 50.2% to 19.1% and provider recommendation or requirement from 72.8% to 47.2%, whereas convenience showed a smaller decline from 65.6% to 56.2% and became the leading reported reason for telehealth use in 2024. Conclusions: Telehealth utilization declined between 2022 and 2024, while the relative persistence of convenience as a reason for use suggests a shift away from pandemic-driven demand toward more selective integration into routine health care. Differences in utilization across population groups suggest that telehealth may address some barriers to conventional care while access remains uneven. These findings highlight the evolving role of telehealth after the COVID-19 PHE and the importance of supporting its appropriate and equitable integration into routine care. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: https://hints.cancer.gov/ I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced are available online at The Health Information National Trends Survey (HINTS) website. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.02.19.26346583v2 "Restoring intended speech in people with dysarthria from pontine stroke using an intracortical brain-computer interface")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.09.26367684v1 "Sex-Specific Incidence of Hemorrhagic Stroke in Japan: An Integrated Population-Based Study") Posted November 10, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/10/2026.11.09.26367679.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.09.26367679v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/10/2026.11.09.26367679.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) The Evolving Role of Telehealth in Routine Health Care Delivery Among US Adults, 2022-2024 Shengyang Wang, Wenxue Lin, Lin Ge medRxiv 2026.11.09.26367679; doi: https://doi.org/10.64898/2026.11.09.26367679 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367679v1%26text%3DThe%2520Evolving%2520Role%2520of%2520Telehealth%2520in%2520Routine%2520Health%2520Care%2520Delivery%2520Among%2520US%2520Adults%252C%25202022-2024 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367679v1%26t%3DThe%2520Evolving%2520Role%2520of%2520Telehealth%2520in%2520Routine%2520Health%2520Care%2520Delivery%2520Among%2520US%2520Adults%252C%25202022-2024 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367679v1%26title%3DThe%2520Evolving%2520Role%2520of%2520Telehealth%2520in%2520Routine%2520Health%2520Care%2520Delivery%2520Among%2520US%2520Adults%252C%25202022-2024%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367679v1%26title%3DThe%2520Evolving%2520Role%2520of%2520Telehealth%2520in%2520Routine%2520Health%2520Care%2520Delivery%2520Among%2520US%2520Adults%252C%25202022-2024 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.09.26367679) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.09.26367679v1&count=horizontal&via=&text=The%20Evolving%20Role%20of%20Telehealth%20in%20Routine%20Health%20Care%20Delivery%20Among%20US%20Adults%2C%202022-2024&counturl=www.medrxiv.org/content/10.64898/2026.11.09.26367679v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (919) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5014) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (428) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (679) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1695) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16281) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7289) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5303) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1473) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1836) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16500) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7615) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1131) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1296) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3751) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (466) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (721) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (786) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6149) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10008) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2539) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1523) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1271) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (663) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (805) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (598) * [Surgery](https://www.medrxiv.org/collection/surgery) (805) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (308) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented
## Related Clinical Research

- [Revolutionizing Female Heart Health: New Life Stage Framework by Medical Societies](https://medichelpline.com/clinical-feed/medical-news-today-1-female-heart-health-top-medical-groups-issue-female-life-stage-framework.md)
- [Four-stage framework for women’s heart health links adolescence through postmenopause](https://medichelpline.com/clinical-feed/stat-news-0-the-4-stages-of-women-s-heart-health-experts-present-new-framework.md)
- [Insomnia linked to higher risk of stroke and hospital admission, major review finds](https://medichelpline.com/clinical-feed/medical-news-today-0-major-review-links-insomnia-to-increased-risk-of-hospitalization-and-stroke.md)
- [USPSTF to meet after yearlong pause to review key preventive recommendations](https://medichelpline.com/clinical-feed/stat-news-0-stat-influential-preventive-services-panel-to-meet-for-first-time-in-more-than.md)
- [Impact of Drug Decriminalization on Mental Health: Insights from Oregon and Washington](https://medichelpline.com/clinical-feed/medrxiv-1-drug-decriminalization-and-population-mental-distress-evidence-from-oregon-and.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.